4503:TYO
Astellas Pharma Inc
JP¥2.320,50
arrow_upward
+1,16%(+26,50) 1D
30 ກ.ຍ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4503...
Open
JP¥2.296
High
JP¥2.334
Low
JP¥2.264
Mkt. cap
4,20 ລ້ານລ້ານ
Avg. vol.
5,89 ລ້ານ
Volume
8,78 ລ້ານ
Dividend
3,36%
Quarterly dividend
JP¥20
Ex-dividend date
29 ກ.ຍ. 2026
P/E ratio
11,39
52-wk high
JP¥2.717
52-wk low
JP¥1.558
EPS
JP¥204
Shares outstanding
1,92 ຕື້
No. of employees
14 ພັນ
Open
JP¥2.296
High
JP¥2.334
Low
JP¥2.264
Mkt. cap
4,20 ລ້ານລ້ານ
Avg. vol.
5,89 ລ້ານ
Volume
8,78 ລ້ານ
Dividend
3,36%
Quarterly dividend
JP¥20
Ex-dividend date
29 ກ.ຍ. 2026
P/E ratio
11,39
52-wk high
JP¥2.717
52-wk low
JP¥1.558
EPS
JP¥204
Shares outstanding
1,92 ຕື້
No. of employees
14 ພັນ
News stories
From web sources and news partners
Seeking Alpha
·
21 ຊົ່ວໂມງກ່ອນ
Vir Biotechnology: Astellas Deal Highlights The Platform's Value
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14,1 ພັນ
Founded1 ມ.ສ. 2005
HeadquartersChuo City, ໂຕກຽວ, ຍີ່ປຸ່ນ
SectorPharmaceutical industry
Websiteastellas.com